T Cell Metabolism: MicroRNAs Cap PTEN to Feed the Expanding Crowd  by Vacchio, Melanie S. & Bosselut, Rémy
Immunity
PreviewsT Cell Metabolism: MicroRNAs Cap PTEN
to Feed the Expanding CrowdMelanie S. Vacchio1 and Re´my Bosselut1,*
1Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
*Correspondence: bosselur@helix.nih.gov
http://dx.doi.org/10.1016/j.immuni.2013.05.006
Cell proliferation during T cell development and effector responses require the resetting of metabolic activity
to fit energy and anabolic needs. Henao-Mejia et al., (2013) show a critical role for a specific microRNA family
in this process.Immune responses are energetically
demanding, notably during the cell-prolif-
eration bursts that characterize lympho-
cytedevelopment andeffector responses.
Because resting lymphocytes, the reserve
soldiers of the immune system, are small
cells with limited metabolism, there must
exist mechanisms to adapt nutrient intake
and processing to intra-cellular energy
production and anabolic needs. For
instance, the intense proliferation required
for initial T cell effector responses is sup-
ported by a switch to aerobic glycolysis,
possibly as a means to generate interme-
diates required to make cell structural
components (Wang and Green, 2012).
Both internal sensors and environmental
clues adjust metabolic activities to cell
needs (Wang and Green, 2012). Of partic-
ular importance are TORC1 complexes
that assemble around the kinase mTOR
and control multiple anabolic (e.g., protein
synthesis) and catabolic (e.g., glycolysis)
pathways. Extracellular signals feed into
these complexes, notably through a
signaling cascade initiating at PI-3 kinase
and involving the serine-threonine kinases
PDK1 and Akt (Figure 1) (Finlay and Can-
trell, 2010). In thymocytes and T cells,
this cascade can be activated by a variety
of stimuli, including the T cell antigen re-
ceptor (TCR), cytokine receptors, and the
costimulatory molecule CD28. Henao-
Mejia et al. (2013), in this issue of Immu-
nity, now show that miRNAs control PI-3
kinase activation of mTOR and serve as a
"rheostat" to adapt metabolic activity to
cell needs.
Henao-Mejia et al. initially address a
seemingly unrelated question, namely
the functions of the mir181 family of
miRNAs. The family consists of three
two-gene clusters encoding highly homol-
ogous miRNAs and previously caughtattention because of its potential involve-
ment in intrathymic T cell selection (Li
et al., 2007). Henao-Mejia et al. found
deletion of all three clusters to be lethal,
indicating their importance for develop-
ment. However, whereas animals lacking
two of the clusters fail to thrive, those defi-
cient for only one cluster display no gross
abnormalities. This allows the authors to
focus on the mir181a1b1 cluster, encod-
ing mir181a1 and mir181b1, the most
highly expressed miRNAs in early T cell
precursors (Kirigin et al., 2012). Its disrup-
tion has two main consequences on the
development of ab-lineage thymocytes
(Henao-Mejia et al., 2013). It impairs their
expansion and survival after TCRb gene
rearrangement, reducing the numbers of
CD4+CD8+ ("double-positive," or DP) thy-
mocytes. Most strikingly, it results in an
almost complete absence of iNK T cells,
a unique TCRab subset that recognizes
lipids bound to the MHC-like molecule
CD1d (Constantinides and Bendelac,
2013) .
Why this effect on iNK T cells? Even
though iNK T cells are derived from DP
thymocytes, the effects of mir181a1b1
deletion on their generation are dispropor-
tionally high in comparison to those on DP
thymocytes. iNK T cell selection in the
thymus differs from that of conventional
ab T cells in two critical ways, each
providing a tentative mechanistic clue:
the selecting element (CD1d) is expressed
by DP thymocytes, and the TCR repertoire
of these cells is limited and typically
involves a Va14-Ja18-containing TCRa
chain and a limited set of TCRb chains
(Constantinides and Bendelac, 2013).
However, neither property accounts for
the iNK T cell defect (Henao-Mejia et al.,
2013). CD1d expression is normal on
mir181a1b1-deficient DP cells, and inImmunitymixed bone marrow chimeras, wild-type
DP thymocytes do not restore the genera-
tion of mutant iNK T cells. Generation of
the canonical Va14-Ja18 chain is impaired
in mir181a1b1-deficient thymocytes be-
cause of their diminished survival, and
this quite possibly contributes to the
paucity of iNK T cells. However,
mir181a1b1 disruption impairs the devel-
opment of iNK T precursors expressing a
transgenic Va14-Ja18 TCRa chain, im-
plying effects beyond TCR rearrangement.
There is yet another difference between
iNK T cells and conventional thymocytes,
although not at the selection level: the
former, but not the latter, expand and
undergo effector differentiation in the
thymus, a process that requires their
expression of the transcription factor
PLZF (Constantinides and Bendelac,
2013). Indeed, mir181a1b1 disruption af-
fects the expansion of iNK T precursors,
an effect seen in cells transgenic for the
canonical Va14-Ja18 chain. Mechanistic
clues to this impaired proliferation come
from RNaseq analyses of gene expres-
sion; these analyses show upregulation
of PTEN, a phosphatase that negatively
controls PI-3 kinase signaling. Henao-
Mejia et al. verify increased PTEN expres-
sion and reduced activity of the PI-3
kinase target Akt in mir181a1b1-deficient
cells. Conversely, hundreds of genes are
downregulated in mutant cells, presum-
ably indirectly, and many of these genes
serve key functions in metabolic control.
Accordingly, multiple metabolic indica-
tors, including nutrient-receptor expres-
sion or extra-cellular acidification, a mea-
sure of glycolysis, show reduced activity.
Altogether, these findings identify broad
metabolic defects in mir181a1b1-defi-
cient cells. These defects target glycol-
ysis and synthesis of nucleotides and38, May 23, 2013 ª2013 Elsevier Inc. 847
Figure 1. mir181 Control of PI-3 Kinase Signaling
PI-3 kinase (PI-3K) activates mTOR, through Akt and other intermediates (not depicted). mTOR activation
promotes protein synthesis, nutrient uptake, and increased glycolysis. PI-3 kinase activity is restrained by
the phosphatase PTEN. In proliferating iNK T cell precursors, mir181miRNAs posttranscriptionally reduce
expression of PTEN and thereby adjust activity of Akt and downstream intermediates in response to
increased metabolic needs. In mir181a1b1-deficient mice (left), excessive PTEN expression curtails Akt
and mTOR activation, impeding metabolic adjustment needed for cell proliferation. By reducing PTEN
expression (right), mir181s adjust the activity of the PI-3 kinase pathway to the metabolic requirements
of iNK T cell expansion.
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Previewsproteins, among other processes, but do
not affect oxidative phosphorylation (as
measured by oxygen consumption) or
fatty acid degradation. Disrupting PTEN
expression restores the differentiation
and proliferation of mir181a1b1-deficient
iNK T cells, supporting the conclusion
that the mir181a1b1 cluster is required
for iNK T cell development because it en-
ables PI-3 kinase to increase metabolism
for iNK T precursor expansion.
These conclusions are consistent with
previous studies showing that iNK T cell
development requires the miRNA-pro-
ducing enzyme Dicer and the kinase
PDK1, which actually phosphorylates Akt
(Fedeli et al., 2009; Finlay and Cantrell,
2010). The parallel with PDK1 is striking;
mir181- and PDK1-deficient iNK T precur-
sors are similarly blocked at the stage
where they normally undergo expansion.
These findings unveil a new facet of the
mir181 family. Previous studies, based on
"knock-down" of miRNA expression, had
concluded that these miRNAs are impor-
tant for the specific sensitivity of DP thy-
mocytes to low-avidity TCR ligands, and
therefore for positive selection (Li et al.,
2007). More recently, it was shown that
they modulate signaling by the Notch
pathway (Fragoso et al., 2012). Indeed,
impaired TCR signaling was proposed in
an independent study by Zietara et al.
(2013) to underlie defective iNK T cell
development of mir181-deficient thymo-
cytes. However, Henao-Mejia et al. find
no TCR or Notch signaling defect in their
mir181a1b1-deficient line, and future848 Immunity 38, May 23, 2013 ª2013 Elsevistudies will be needed to resolve this
discrepancy. Deciphering potential ef-
fects on TCR signaling will also require
analyses of thymocytes carrying defined
TCR specificities and of their response
to low-avidity ligands that typically pro-
mote positive selection.
Certainly, one of the most striking as-
pects of this study is to connect miRNA
regulation of gene expression and meta-
bolism control. Work in the last 10 years
has investigated how T cells adjust their
metabolic activity to their energetic and
anabolic needs. Previous studies had
highlighted the importance of the PI-3
kinase pathway for activation of meta-
bolism in thymocytes and developing
iNK T cells (Finlay and Cantrell, 2010).
Why then are miRNAs involved in such
control, andwhy is themir181 requirement
so drastic during iNK T cell differentiation,
unlike at earlier episodes of thymocyte
expansion (Henao-Mejia et al., 2013)?
Although a firm answer to these questions
is still elusive, an intriguing possibility is
that mir181s sensitize the PI-3 kinase
pathway to the paucity of extracellular sig-
nals that in other contexts contribute to its
activation. iNK T cells recognize antigens
presented by DP thymocytes, which do
not provide the panoply of costimulatory
signals produced by professional anti-
gen-presenting cells and which reside in
the cytokine-depleted thymic cortex,
further limiting extra-cellular cues for iNK
T cell precursors. Thus, an attractive sce-
nario is that mir181s tune the sensitivity of
the PI-3 kinase pathway to enable celler Inc.proliferation despite minimal environ-
mental input.
Is it possible that miRNA "rheostats"
similar to that identified by Henao-Mejia
et al., although not necessarily mir181
based, serve in other settings to adjust
the activity of metabolic pathways to cell
needs? Such mechanisms could be
involved as effector T cells encounter
rapidly changing concentrations of nutri-
ents and oxygen, in lymphoid organs or
tissue effector sites. In addition, miRNA-
based mechanisms could fine-tune meta-
bolic programs specific of defined stages
of the immune response, or of distinct
effector fates. For instance, whereas early
effector responses require aerobic glycol-
ysis, memory cells depend on fatty acid
degradation (Pearce et al., 2009), a
pathway unaffected by mir181a1b1
disruption (Henao-Mejia et al., 2013).
MicroRNAs, with their potential for target-
ing of key enzymatic regulators control-
ling these pathways, as epitomized by
Henao-Mejia et al., appear ideally suited
to provide rapid responses to changing
environmental conditions.
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